openPR Logo
Press release

Head and Neck Cancer Drugs Market - Increase In Use Of Combination Therapy And Growth In Demand For Target Immune Therapy Are Expected To Boost The Market Growth In The Coming Years

06-14-2019 09:06 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Head and Neck Cancer Drugs Market

Head and Neck Cancer Drugs Market

Recent launch of novel drugs for treatment of head and neck cancer, rise in geriatric population across the world, and surge in consumption of tobacco & alcohol has fueled the growth of global head & neck cancer drugs market.

Allied Market Research recently published a report, titled, “Head and Neck Cancer Drugs Market by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores): Global Opportunity Analysis and Industry Forecast, 2018–2025”. According to the report, the global head & neck cancer drugs market accounted for $1.30 billion in 2017 and is projected to $2.28 billion by 2025, registering a CAGR of 7.3% during the period from 2018 to 2025.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/5174

Segmentation Analysis of the Industry
The market is divided on the basis of drug class, sales channel, and geography. Based on drug class, the market is segmented into chemotherapy, immunotherapy, and targeted therapy. The chemotherapy segment held the largest share in 2017, contributing nearly half of the total market share. However, the immunotherapy segment is expected to manifest the fastest CAGR of 12.1% during the forecast period.

On the basis of sales channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies, and online stores. The drug stores & retail pharmacies segment dominated the market in terms of revenue, contributing about 58% of the total market share in 2017. However, the online stores segment is projected to portray the fastest CAGR of 10.2% through 2025.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA). North America region held the largest share in 2017, accounting about half of the total market. However, Asia-Pacific region is estimated to manifest the fastest CAGR of 9.7% during the forecast period.
Industry Key Players

The report includes the major market players in the industry, such as AstraZeneca PLC, Eli Lilly and Company (ARMO Biosciences), F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), Immutep Limited, Merck KGaA (EMD Serono, Inc.), and Pfizer Inc.

Purchase This Report with Discounted Price @ https://www.alliedmarketresearch.com/checkout-final/f95b22bb1917e9967a3a67c35a62112f

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Head and Neck Cancer Drugs Market - Increase In Use Of Combination Therapy And Growth In Demand For Target Immune Therapy Are Expected To Boost The Market Growth In The Coming Years here

News-ID: 1775479 • Views: 450

More Releases from Allied Market Research

Neuropeptide Y Receptor Market to Obtain Awesome Hike in Revenues
Global Neuropeptide Y Receptor Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Neuropeptide Y Receptor Market by Product (Food Grade and Pharmaceutical
Infused Dried Fruits Market Size is Set for Rapid Growth and Industry Trend by 2 …
Infused dried fruits are infused with fruit sugar solution through osmotic pressure and dried at 60°C temperature. These fruits have low calories and have low added sugar. The infused dried fruit companies have to follow standards like HACCP, BRC, IFS, and ISO22000. The infused dried fruits are vegan products that have high vitamin C, and are gluten and GMO-free. These products are also suitable for diabetics because they do not
Plant-based Food Market Growing Demand, Production Scope and Revenue 2020 to 202 …
Plant-based food refers to the food products derived from plant sources, which include fruits, vegetables, whole grains, tofu, seeds, beans, lentils, and soy. Unlike a few years ago, plant-based foods are now available conveniently in most grocery stores. The plant-based foods niche market has grown into a completely mainstream industry, since the dominant meat consumers are have shifted their preference toward plant-based meat and dairy alternatives. Download Sample Report with
Cocoa Butter Market Analysis, Trends, Top Manufacturers, Share, Growth, Statisti …
Cocoa butter is a pale-yellow, edible vegetable fat, which is obtained from cocoa beans. This butter consists of diversified fatty acids such as stearic acid, arachidic acid, palmitic acid, myristic acid, and lauric acid. Cocoa butter serves as a key ingredient in making chocolate and confectionery products, as it is soft in texture and contains exotic flavor and aroma. Moreover, it is used in personal care products such as skin

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning